person

Elisa M.

Country
Italy
Department
S.C. Clinica Pediatrica

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 62 partner sites.

Specializations

Lung Cancer Research

This investigator specializes in the treatment of advanced non-small cell lung cancer (NSCLC), with particular focus on developing therapeutic strategies for patients who have experienced disease progression after initial treatments.

  • Advanced NSCLC Management
  • Treatment-Resistant Lung Cancer
  • Combination Therapy Approaches

Their research explores innovative therapeutic combinations for patients who have progressed following immunotherapy and chemotherapy treatments.

Immunotherapy

The investigator's work centers on immunotherapeutic approaches in lung cancer treatment, specifically examining the role of various immunotherapy agents in combination with conventional treatments.

  • Novel Immunotherapy Combinations
  • Post-Immunotherapy Treatment Strategies
  • Immune Checkpoint Inhibition

Their research investigates therapeutic solutions for patients who have previously received PD-1/PD-L1 targeted treatments.

Treatment Innovation

The investigator focuses on developing advanced therapeutic strategies that combine multiple treatment modalities to improve outcomes in resistant lung cancer cases.

  • Multi-Modal Treatment Approaches
  • Sequential Therapy Development
  • Treatment Optimization Studies

Their work explores the integration of novel agents with established treatments to enhance therapeutic efficacy.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.